189 related articles for article (PubMed ID: 34868557)
21. High accuracy of proximity extension assay technology for the quantification of plasma brain natriuretic peptide.
Arrigo M; Vodovar N; Von Moos S; Masson E; Segerer S; Cippà PE; Mebazaa A
J Clin Lab Anal; 2018 Oct; 32(8):e22574. PubMed ID: 29797353
[TBL] [Abstract][Full Text] [Related]
22. Identification of potential serum biomarkers for Wilms tumor after excluding confounding effects of common systemic inflammatory factors.
Wang J; Wang L; Zhang D; Fan Y; Jia Z; Qin P; Yu J; Zheng S; Yang F
Mol Biol Rep; 2012 May; 39(5):5095-104. PubMed ID: 22160518
[TBL] [Abstract][Full Text] [Related]
23. Serum biomarker modulation following molecular targeting of epidermal growth factor and cyclooxygenase pathways: a pilot randomized trial in head and neck cancer.
Moskowitz HS; Gooding WE; Thomas SM; Freilino ML; Gross N; Argiris A; Grandis JR; Ferris RL
Oral Oncol; 2012 Nov; 48(11):1136-45. PubMed ID: 22732263
[TBL] [Abstract][Full Text] [Related]
24. Using reverse-phase protein arrays as pharmacodynamic assays for functional proteomics, biomarker discovery, and drug development in cancer.
Lu Y; Ling S; Hegde AM; Byers LA; Coombes K; Mills GB; Akbani R
Semin Oncol; 2016 Aug; 43(4):476-83. PubMed ID: 27663479
[TBL] [Abstract][Full Text] [Related]
25. A Targeted Mass Spectrometry Strategy for Developing Proteomic Biomarkers: A Case Study of Epithelial Ovarian Cancer.
Hüttenhain R; Choi M; Martin de la Fuente L; Oehl K; Chang CY; Zimmermann AK; Malander S; Olsson H; Surinova S; Clough T; Heinzelmann-Schwarz V; Wild PJ; Dinulescu DM; Niméus E; Vitek O; Aebersold R
Mol Cell Proteomics; 2019 Sep; 18(9):1836-1850. PubMed ID: 31289117
[TBL] [Abstract][Full Text] [Related]
26. Folate-receptor 1 (FOLR1) protein is elevated in the serum of ovarian cancer patients.
Leung F; Dimitromanolakis A; Kobayashi H; Diamandis EP; Kulasingam V
Clin Biochem; 2013 Oct; 46(15):1462-8. PubMed ID: 23528302
[TBL] [Abstract][Full Text] [Related]
27. Comparative Analysis of Multiplex Platforms for Detecting Vitreous Biomarkers in Diabetic Retinopathy.
Lamy R; Farber-Katz S; Vives F; Ayanoglu G; Zhao T; Chen Y; Laotaweerungsawat S; Ma D; Phone A; Psaras C; Li NX; Sutradhar S; Carrington PE; Stewart JM
Transl Vis Sci Technol; 2020 Sep; 9(10):3. PubMed ID: 32953243
[TBL] [Abstract][Full Text] [Related]
28. Using protein microarray to identify and evaluate autoantibodies to tumor-associated antigens in ovarian cancer.
Ma Y; Wang X; Qiu C; Qin J; Wang K; Sun G; Jiang D; Li J; Wang L; Shi J; Wang P; Ye H; Dai L; Jiang BH; Zhang J
Cancer Sci; 2021 Feb; 112(2):537-549. PubMed ID: 33185955
[TBL] [Abstract][Full Text] [Related]
29. Multi-platform Affinity Proteomics Identify Proteins Linked to Metastasis and Immune Suppression in Ovarian Cancer Plasma.
Graumann J; Finkernagel F; Reinartz S; Stief T; Brödje D; Renz H; Jansen JM; Wagner U; Worzfeld T; Pogge von Strandmann E; Müller R
Front Oncol; 2019; 9():1150. PubMed ID: 31737572
[TBL] [Abstract][Full Text] [Related]
30. Serum protein profile at remission can accurately assess therapeutic outcomes and survival for serous ovarian cancer.
Wang J; Sharma A; Ghamande SA; Bush S; Ferris D; Zhi W; He M; Wang M; Wang X; Miller E; Hopkins D; Macfee M; Guan R; Tang J; She JX
PLoS One; 2013; 8(11):e78393. PubMed ID: 24244307
[TBL] [Abstract][Full Text] [Related]
31. Multiplex proteomics using proximity extension assay for the identification of protein biomarkers predictive of acute graft-vs.-host disease in allogeneic hematopoietic cell transplantation.
Pasic I; Ren AH; Nampoothiri RV; Prassas I; Lipton JH; Mattsson J; Diamandis EP; Michelis FV
Clin Chem Lab Med; 2023 May; 61(6):1005-1014. PubMed ID: 36655501
[TBL] [Abstract][Full Text] [Related]
32. Blood Proteomics Analysis Reveals Potential Biomarkers and Convergent Dysregulated Pathways in Autism Spectrum Disorder: A Pilot Study.
Mesleh A; Ehtewish H; de la Fuente A; Al-Shamari H; Ghazal I; Al-Faraj F; Al-Shaban F; Abdesselem HB; Emara M; Alajez NM; Arredouani A; Decock J; Albagha O; Stanton LW; Abdulla SA; El-Agnaf OMA
Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108604
[TBL] [Abstract][Full Text] [Related]
33. Serum S100A6 concentration predicts peritoneal tumor burden in mice with epithelial ovarian cancer and is associated with advanced stage in patients.
Wei BR; Hoover SB; Ross MM; Zhou W; Meani F; Edwards JB; Spehalski EI; Risinger JI; Alvord WG; Quiñones OA; Belluco C; Martella L; Campagnutta E; Ravaggi A; Dai RM; Goldsmith PK; Woolard KD; Pecorelli S; Liotta LA; Petricoin EF; Simpson RM
PLoS One; 2009 Oct; 4(10):e7670. PubMed ID: 19888321
[TBL] [Abstract][Full Text] [Related]
34. Serum peptidome profiling revealed platelet factor 4 as a potential discriminating Peptide associated with pancreatic cancer.
Fiedler GM; Leichtle AB; Kase J; Baumann S; Ceglarek U; Felix K; Conrad T; Witzigmann H; Weimann A; Schütte C; Hauss J; Büchler M; Thiery J
Clin Cancer Res; 2009 Jun; 15(11):3812-9. PubMed ID: 19470732
[TBL] [Abstract][Full Text] [Related]
35. Gel-Based Proteomics of Clinical Samples Identifies Potential Serological Biomarkers for Early Detection of Colorectal Cancer.
Thorsen SF; Gromova I; Christensen IJ; Fredriksson S; Andersen CL; Nielsen HJ; Stenvang J; Moreira JMA
Int J Mol Sci; 2019 Dec; 20(23):. PubMed ID: 31810358
[TBL] [Abstract][Full Text] [Related]
36. Identification of five serum protein markers for detection of ovarian cancer by antibody arrays.
Jiang W; Huang R; Duan C; Fu L; Xi Y; Yang Y; Yang WM; Yang D; Yang DH; Huang RP
PLoS One; 2013; 8(10):e76795. PubMed ID: 24116163
[TBL] [Abstract][Full Text] [Related]
37. Multiplex targeted proteomic assay for biomarker detection in plasma: a pancreatic cancer biomarker case study.
Pan S; Chen R; Brand RE; Hawley S; Tamura Y; Gafken PR; Milless BP; Goodlett DR; Rush J; Brentnall TA
J Proteome Res; 2012 Mar; 11(3):1937-48. PubMed ID: 22316387
[TBL] [Abstract][Full Text] [Related]
38. Diagnostic Value of Serum Angiogenesis Markers in Ovarian Cancer Using Multiplex Immunoassay.
Horala A; Swiatly A; Matysiak J; Banach P; Nowak-Markwitz E; Kokot ZJ
Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28075407
[TBL] [Abstract][Full Text] [Related]
39. Quantitative assessment of serum heat shock protein 27 for the diagnosis of epithelial ovarian cancer using targeted proteomics coupled with immunoaffinity enrichment.
Yang T; Xu P; Gu L; Xu Z; Ge W; Li Q; Xu F
Clin Chim Acta; 2019 Feb; 489():96-102. PubMed ID: 30502327
[TBL] [Abstract][Full Text] [Related]
40. Proteomic profiling identifies afamin as a potential biomarker for ovarian cancer.
Jackson D; Craven RA; Hutson RC; Graze I; Lueth P; Tonge RP; Hartley JL; Nickson JA; Rayner SJ; Johnston C; Dieplinger B; Hubalek M; Wilkinson N; Perren TJ; Kehoe S; Hall GD; Daxenbichler G; Dieplinger H; Selby PJ; Banks RE
Clin Cancer Res; 2007 Dec; 13(24):7370-9. PubMed ID: 18094419
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
